The value of urinary fibrin/fibrinogen degradation products as tumor markers in urothelial carcinoma.
Urinary fibrin/fibrinogen degradation products as biological tumor markers in urothelial carcinoma have been studied and compared to urinary cytology. In 93 per cent of the patients with urothelial carcinoma urinary fibrin/fibrinogen degradation product levels were elevated significantly. There was excellent correlation when the urinary cytology and urinary fibrin/fibrinogen degradation product results were compared together to cystoscopic findings.
D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000652:urine*; D003558:Cystoscopy; D005338:Fibrin Fibrinogen Degradation Products / Q000652:urine*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000652:urine*; D011446:Prospective Studies; D011863:Radioimmunoassay; D011933:Reagent Kits, Diagnostic; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000652:urine*
D005338:Fibrin Fibrinogen Degradation Products; D011933:Reagent Kits, Diagnostic